At a glance
ClinicalIndex Comparison RecordN/ACompleted· 198 enrolled
Drug / intervention
transcranial direct current stimulation (tDCS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Demonstration Study of the Effect of the Transcranial Direct Current Stimulation (tDCS) for the Patients With Depression in Clinical Fields
In Brief
A clinical study evaluating transcranial direct current stimulation (tDCS) for Depression. Completed, enrolled 198 participants across 5 sites.
Detailed Summary
Purpose of research: It aims to demonstrate the effectiveness of transcranial direct current stimulation (tDCS) in the clinical domain for patients with depression and to optimize home-based e-medication technology.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedSep 2022
Enrollment StartNov 2022
Primary CompletionOct 2024
Study CompletionDec 2024
TodayJul 2026
First PostedSep 14, 2022
Enrollment StartNov 4, 2022
Primary CompletionOct 31, 2024
Study CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 3.8 years ago
Interventions
transcranial direct current stimulation (tDCS)device
Transcranial direct current stimulation (tDCS) suppresses excitability and regulates excitability of neurons by injecting a small amount of current through electrodes attached to the scalp.